Skip to main content
  • Sapien 3 Results 'Remarkable' for High-Risk Patients PARTNER II data with latest device "sets the bar very high," interventionalists say

    The latest generation Sapien 3 device for transcatheter aortic valve replacement (TAVR) had good safety and outcomes in high-risk and inoperable patients, a PARTNER II substudy found.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details